Participation will involve one assessment session approximating 4 hours including administration of neurocognitive and socioemotional measures by trained research staff. The research team then will determine which participants meet CAPD diagnostic criteria for both the SCAN-3 and RGDT tests and assign them to the ASD+ group. Participants not meeting these criteria will be assigned to the ASD- group. Following the assessment visit, all participants will then be asked to wear actigraphy monitors (comparable to overnight polysomnography) regularly for 14 days during nighttime sleep to objectively measure sleep quality.
Age
6–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Have diagnosis of Autism Spectrum Disorder confirmed by the Autism Diagnostic Observation Schedule and the Social Communication Questionnaire, Lifetime Version which will be filled by the parent
IQ of 50 or higher on the Abbreviated Battery IQ Score
You may not be if
No confirmed diagnosis of Autism Spectrum Disorder
History of sleep apnea
History of restless leg syndrome
History of any neurological disorders (e.g., seizures, tumors, etc.)
Significant substance use in the past six months
Inpatient hospitalization in the past three months-period
Clareo Health | Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder
